Loading…

Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium

The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the abs...

Full description

Saved in:
Bibliographic Details
Published in:Circulation research 1998-03, Vol.82 (4), p.473-481
Main Authors: de Hurtado, Maria C. Camilion, Alvarez, Bernardo V, Perez, Nestor G, Ennis, Irene L, Cingolani, Horacio E
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 481
container_issue 4
container_start_page 473
container_title Circulation research
container_volume 82
creator de Hurtado, Maria C. Camilion
Alvarez, Bernardo V
Perez, Nestor G
Ennis, Irene L
Cingolani, Horacio E
description The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P
doi_str_mv 10.1161/01.res.82.4.473
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79733083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79733083</sourcerecordid><originalsourceid>FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813</originalsourceid><addsrcrecordid>eNo9kDFPwzAQhS0EKqUwMyFlQCzIwY6dxB6rqtBIhS6UNXKcSxtwk2InlP57XLViuTvd--6k9xC6pSSkNKFPhIYWXCiikIc8ZWdoSOOIYx6n9BwNCSESp4yRS3Tl3CchlLNIDtBAxiRJiRii5bhZ1W0HjaubIMuCse7qH9WBC97UI86aErbgS9MFE4PxbLJgOJj-6rVqVhD4kw8v2Vr3Rtngdd9qZcu631yji0oZBzenPkLL5-n7ZIbni5dsMp7jNaNc4lLxKtGKpVrzMuYiLiqpEknLgotSMZZwzSABKtKCR0CLRHABaUJYDN6KoGyEHo5_t7b97sF1-aZ2GoxRDbS9y1N5MC-YB-9OYF9soMy3tt4ou89POXj9_qQrp5WprGp07f6xiEoupfQYP2K71nRg3Zfpd2DzNSjTrXOfNmGERphKKfwkCT6sJPsDbOl6BA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79733083</pqid></control><display><type>article</type><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><source>Freely Accessible Science Journals</source><creator>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</creator><creatorcontrib>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</creatorcontrib><description>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P&lt;.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P&lt;.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.res.82.4.473</identifier><identifier>PMID: 9506708</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Alkaloids ; Amiloride - analogs &amp; derivatives ; Amiloride - pharmacology ; Angiotensin II - physiology ; Angiotensin Receptor Antagonists ; Animals ; Antiporters - metabolism ; Benzophenanthridines ; Bicarbonates - metabolism ; Biological and medical sciences ; Cats ; Chloride-Bicarbonate Antiporters ; Chlorides - metabolism ; Enzyme Inhibitors - pharmacology ; Fundamental and applied biological sciences. Psychology ; Heart ; Heart Ventricles - metabolism ; Hydrogen-Ion Concentration ; In Vitro Techniques ; Losartan - pharmacology ; Myocardium - metabolism ; Phenanthridines - pharmacology ; Protein Kinase C - antagonists &amp; inhibitors ; Receptor, Angiotensin, Type 1 ; Receptor, Angiotensin, Type 2 ; Signal Transduction ; Sodium - metabolism ; Sodium-Hydrogen Exchangers - antagonists &amp; inhibitors ; Vertebrates: cardiovascular system</subject><ispartof>Circulation research, 1998-03, Vol.82 (4), p.473-481</ispartof><rights>1998 American Heart Association, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2194999$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9506708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Hurtado, Maria C. Camilion</creatorcontrib><creatorcontrib>Alvarez, Bernardo V</creatorcontrib><creatorcontrib>Perez, Nestor G</creatorcontrib><creatorcontrib>Ennis, Irene L</creatorcontrib><creatorcontrib>Cingolani, Horacio E</creatorcontrib><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P&lt;.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P&lt;.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</description><subject>Alkaloids</subject><subject>Amiloride - analogs &amp; derivatives</subject><subject>Amiloride - pharmacology</subject><subject>Angiotensin II - physiology</subject><subject>Angiotensin Receptor Antagonists</subject><subject>Animals</subject><subject>Antiporters - metabolism</subject><subject>Benzophenanthridines</subject><subject>Bicarbonates - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cats</subject><subject>Chloride-Bicarbonate Antiporters</subject><subject>Chlorides - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart</subject><subject>Heart Ventricles - metabolism</subject><subject>Hydrogen-Ion Concentration</subject><subject>In Vitro Techniques</subject><subject>Losartan - pharmacology</subject><subject>Myocardium - metabolism</subject><subject>Phenanthridines - pharmacology</subject><subject>Protein Kinase C - antagonists &amp; inhibitors</subject><subject>Receptor, Angiotensin, Type 1</subject><subject>Receptor, Angiotensin, Type 2</subject><subject>Signal Transduction</subject><subject>Sodium - metabolism</subject><subject>Sodium-Hydrogen Exchangers - antagonists &amp; inhibitors</subject><subject>Vertebrates: cardiovascular system</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9kDFPwzAQhS0EKqUwMyFlQCzIwY6dxB6rqtBIhS6UNXKcSxtwk2InlP57XLViuTvd--6k9xC6pSSkNKFPhIYWXCiikIc8ZWdoSOOIYx6n9BwNCSESp4yRS3Tl3CchlLNIDtBAxiRJiRii5bhZ1W0HjaubIMuCse7qH9WBC97UI86aErbgS9MFE4PxbLJgOJj-6rVqVhD4kw8v2Vr3Rtngdd9qZcu631yji0oZBzenPkLL5-n7ZIbni5dsMp7jNaNc4lLxKtGKpVrzMuYiLiqpEknLgotSMZZwzSABKtKCR0CLRHABaUJYDN6KoGyEHo5_t7b97sF1-aZ2GoxRDbS9y1N5MC-YB-9OYF9soMy3tt4ou89POXj9_qQrp5WprGp07f6xiEoupfQYP2K71nRg3Zfpd2DzNSjTrXOfNmGERphKKfwkCT6sJPsDbOl6BA</recordid><startdate>19980309</startdate><enddate>19980309</enddate><creator>de Hurtado, Maria C. Camilion</creator><creator>Alvarez, Bernardo V</creator><creator>Perez, Nestor G</creator><creator>Ennis, Irene L</creator><creator>Cingolani, Horacio E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19980309</creationdate><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><author>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Alkaloids</topic><topic>Amiloride - analogs &amp; derivatives</topic><topic>Amiloride - pharmacology</topic><topic>Angiotensin II - physiology</topic><topic>Angiotensin Receptor Antagonists</topic><topic>Animals</topic><topic>Antiporters - metabolism</topic><topic>Benzophenanthridines</topic><topic>Bicarbonates - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cats</topic><topic>Chloride-Bicarbonate Antiporters</topic><topic>Chlorides - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart</topic><topic>Heart Ventricles - metabolism</topic><topic>Hydrogen-Ion Concentration</topic><topic>In Vitro Techniques</topic><topic>Losartan - pharmacology</topic><topic>Myocardium - metabolism</topic><topic>Phenanthridines - pharmacology</topic><topic>Protein Kinase C - antagonists &amp; inhibitors</topic><topic>Receptor, Angiotensin, Type 1</topic><topic>Receptor, Angiotensin, Type 2</topic><topic>Signal Transduction</topic><topic>Sodium - metabolism</topic><topic>Sodium-Hydrogen Exchangers - antagonists &amp; inhibitors</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Hurtado, Maria C. Camilion</creatorcontrib><creatorcontrib>Alvarez, Bernardo V</creatorcontrib><creatorcontrib>Perez, Nestor G</creatorcontrib><creatorcontrib>Ennis, Irene L</creatorcontrib><creatorcontrib>Cingolani, Horacio E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Hurtado, Maria C. Camilion</au><au>Alvarez, Bernardo V</au><au>Perez, Nestor G</au><au>Ennis, Irene L</au><au>Cingolani, Horacio E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1998-03-09</date><risdate>1998</risdate><volume>82</volume><issue>4</issue><spage>473</spage><epage>481</epage><pages>473-481</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P&lt;.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P&lt;.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9506708</pmid><doi>10.1161/01.res.82.4.473</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7330
ispartof Circulation research, 1998-03, Vol.82 (4), p.473-481
issn 0009-7330
1524-4571
language eng
recordid cdi_proquest_miscellaneous_79733083
source Freely Accessible Science Journals
subjects Alkaloids
Amiloride - analogs & derivatives
Amiloride - pharmacology
Angiotensin II - physiology
Angiotensin Receptor Antagonists
Animals
Antiporters - metabolism
Benzophenanthridines
Bicarbonates - metabolism
Biological and medical sciences
Cats
Chloride-Bicarbonate Antiporters
Chlorides - metabolism
Enzyme Inhibitors - pharmacology
Fundamental and applied biological sciences. Psychology
Heart
Heart Ventricles - metabolism
Hydrogen-Ion Concentration
In Vitro Techniques
Losartan - pharmacology
Myocardium - metabolism
Phenanthridines - pharmacology
Protein Kinase C - antagonists & inhibitors
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Signal Transduction
Sodium - metabolism
Sodium-Hydrogen Exchangers - antagonists & inhibitors
Vertebrates: cardiovascular system
title Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A46%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20Activates%20Na+-Independent%20Cl--HCO3-%20Exchange%20in%20Ventricular%20Myocardium&rft.jtitle=Circulation%20research&rft.au=de%20Hurtado,%20Maria%20C.%20Camilion&rft.date=1998-03-09&rft.volume=82&rft.issue=4&rft.spage=473&rft.epage=481&rft.pages=473-481&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.res.82.4.473&rft_dat=%3Cproquest_pubme%3E79733083%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79733083&rft_id=info:pmid/9506708&rfr_iscdi=true